STRATA Skin Sciences, Inc. (SSKN) Earnings History
Annual and quarterly earnings data from 2003 to 2024
Loading earnings history...
SSKN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SSKN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 56.9% | -27.6% | -30.1% |
| 2023 | 55.3% | -25.8% | -32.5% |
| 2022 | 60.2% | -12.9% | -15.3% |
| 2021 | 66.2% | -14.7% | -9.0% |
| 2020 | 61.2% | -17.7% | -19.1% |
Download Data
Export SSKN earnings history in CSV or JSON format
Free sign-in required to download data
STRATA Skin Sciences, Inc. (SSKN) Earnings Overview
As of May 8, 2026, STRATA Skin Sciences, Inc. (SSKN) reported trailing twelve-month net income of -$11M, reflecting +16.1% year-over-year growth. The company earned $-0.25 per diluted share over the past four quarters, with a net profit margin of -30.1%.
Looking at the long-term picture, SSKN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2003.
STRATA Skin Sciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including DERM (-$9M net income, -26.1% margin), SKIN (-$6M net income, -3.2% margin), LNTH ($279M net income, 15.2% margin), SSKN has room to improve margins relative to the peer group. Compare SSKN vs DERM →
SSKN Earnings vs Peers
Earnings metrics vs comparable public companies
SSKN Historical Earnings Data (2003–2024)
22 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$10M | +6.9% | -$9M | $-0.26 | -30.1% | -27.6% |
| 2023 | -$11M | -95.2% | -$9M | $-0.31 | -32.5% | -25.8% |
| 2022 | -$6M | -105.1% | -$5M | $-0.16 | -15.3% | -12.9% |
| 2021 | -$3M | +38.7% | -$4M | $-0.08 | -9.0% | -14.7% |
| 2020 | -$4M | -16.4% | -$4M | $-0.13 | -19.1% | -17.7% |
| 2019 | -$4M | +6.0% | -$3M | $-0.12 | -12.0% | -9.5% |
| 2018 | -$4M | +81.3% | -$3M | $-0.15 | -13.5% | -11.2% |
| 2017 | -$22M | -545.1% | -$2M | $-3.26 | -68.4% | -7.7% |
| 2016 | -$3M | +88.1% | -$4M | $-1.44 | -10.5% | -11.3% |
| 2015 | -$28M | -74.1% | -$16M | $-163.46 | -150.9% | -89.1% |
See SSKN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SSKN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SSKN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSSKN — Frequently Asked Questions
Quick answers to the most common questions about buying SSKN stock.
Is SSKN growing earnings?
SSKN EPS is $-0.25, with earnings growth accelerating to +16.1%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-11M.
What are SSKN's profit margins?
STRATA Skin Sciences, Inc. net margin is -30.1%, with operating margin at -27.6%. Below-average margins reflect competitive or cost pressures.
How consistent are SSKN's earnings?
SSKN earnings data spans 2003-2024. The accelerating earnings trend is +16.1% YoY. Historical data enables comparison across business cycles.